The tyrosine kinase receptor ALK is found rearranged, mostly with Echinoderm Microtubule-Associated Protein-like 4 (EMLA4), in approximately 5% of NSCLC patients, causing inappropriate signaling which induces an activated state in cancer cells [63]. Here, ALK is linked to non-small cell lung carcinoma.